Labiotech.eu

News and Trends 15 Feb 2016

Celebrating the 10th Birthday of this German Infectious Disease Biotech with the CEO

AiCuris is a Biotech company based on the Bayer Life Sciences park in Wuppertal (Germany). It is working on new anti-infective drugs and is a former spin-off of Germany’s biggest Pharma Company. It’s celebrating its 10th birthday this year, which is good reason to interview the CEO… So AiCuris is working on anti-infective drugs for […]

February 15, 2016 - 4 minutesmins - By Philip Hemme

News and Trends 13 Feb 2016

What happened this week? 8 great innovators, PD-L1 combo, Genzyme

Monday: Here are 8 of Forbes’ Under 30 Year Olds Transforming European Biotech Tuesday: Immuno-Oncology Combo works on Lung Cancer Regardless of PD-L1 Type Wednesday: What’s the situation in France two weeks after the Trial Failure? Thursday: Why is Genzyme still Crazy Successful 5 Years after Sanofi’s Acquisition? Friday: World’s Largest Genome Sequencing Project partners […]

February 13, 2016 - 1 minutemin - By Philip Hemme

News and Trends 12 Feb 2016

World’s Largest Genome Sequencing Project partners with Global Leader in NGS

Genomics England (UK) today announce a partnership with the Next-Generation Sequencing Giant, Illumina (US), to develop a platform that can be used to improve and automate genome interpretation as part of the 100,000 Genome Project. The tools will operate within the Genomics England secure database to enable researchers and clinicians to access information and reports more readily. […]

February 12, 2016 - 2 minutesmins - By Dani Bancroft

News and Trends 12 Feb 2016

Biotech of the week: Nordic Nanovector & its ARC technology

This week we say ‘au revoir’ to Nantes and head back up to the Scandinavian country that is Norway, in particular it’s capital city, Oslo – the location of our biotech of the week, Nordic Nanovector. City: Oslo, Norway Founded: 2009 Employees: +/- 30 (as off 11/15) Financial Data: €156M Market Cap (on 23/11/2015) CEO: Missions: Betalutin, a potential new treatment […]

February 12, 2016 - 1 minutemin - By Philip Hemme

News and Trends 11 Feb 2016

Sanofi-Genzyme: Still successful 5 years after the acquisition?

Back in 2011, France’s biggest Pharmaceutical company Sanofi decided to purchase Genzyme Corp. for more than $20 billion, thus becoming the latest global drug giant to acquire a big biotech to foster its R&D pipeline. 5 years later, what’s the situation for Genzyme and Sanofi? So often when a large Pharma acquires a smaller Biotech, […]

February 11, 2016 - 3 minutesmins - By Dani Bancroft

News and Trends 10 Feb 2016

“Actelion could be the First European-born Biopharma to make it to the Major League”

This is what the founder & CEO Jean-Paul Clozel of Actelion (Switzerland) said at the announcement of the 2015 financial results for the company. And it’s definitely true. Actelion is the only European born biopharma to have over 1K employees (in fact over 2,547 of them). This is already a big achievement but not their greatest… For example, in 2015, […]

February 10, 2016 - 2 minutesmins - By Philip Hemme

News and Trends 9 Feb 2016

When the Biggest Tech Investors Go Wild for Biotech

Biotech is catching new investors’ interest. Just in 2015, Google Ventures, the accelerator Y Combinator, Andreessen Horowitz (one of the most successful early-stage investment funds in the Valley) and Peter Thiel (founder of Paypal) showed their interest in Biotech. Why? And why now? Andreessen Horowitz is the investment fund created by Marc Andreessen (founder of Netscape) and […]

February 9, 2016 - 5 minutesmins - By Philip Hemme

News and Trends 9 Feb 2016

Synthetic Biology Breakthrough in Production of Natural Carotenoids

The SynBio Biotech, Deinove (France), is hoping to break into the Carotenoid market for food, cosmetics and animal feed. Now, with their Deinococcus platform they have made several major advancements in their endeavours. Deinove also partnered with the Canadian company POS Bio-Sciences last year to try and kickstart the long-term project. Carotenoids are part of the isoprenoid family, which is the main area of […]

February 9, 2016 - 3 minutesmins - By Dani Bancroft

News and Trends 8 Feb 2016

The European Union Finances the Future of CAR-T Manufacturing

CAR-T is the way forward in Cancer therapeutics, which is one of the leading causes of Mortality in the Western world. Now this European consortium has amassed €6M for a more unified approach to CAR-T under a European Union Commission program. In response to this major health issue Miltenyi Biotec (Germany) coordinates the new EU-funded project […]

February 8, 2016 - 3 minutesmins - By Dani Bancroft

News and Trends 8 Feb 2016

French Biotech Launches Phase III Global Trial for Lung Cancer Drug

OSE Pharma (France) has initiated the US phase III trial, Atalante 1. This global, pivotal trial will evaluate Tedopi, the company’s lead product, for advanced non-small cell lung cancer (NSCLC). The phase III study was initiated in Europe in early 2016, so the screening of eligible patients diagnosed with non-small cell lung cancer is now actively ongoing in […]

February 8, 2016 - 2 minutesmins - By Dani Bancroft

News and Trends 8 Feb 2016

Here are 8 of Forbes’ Under 30 Year Olds Transforming European Biotech

Here are 8 of the top European innovators under 30 which are part of the Biotech Ecosystem… After reading Forbes ’30 Under 30′ ranking in the Science and Healthcare field in Europe, we decided to list a few of these impressive individuals – one as young as 18 years old! The panel of judges was made up […]

February 8, 2016 - 4 minutesmins - By Dani Bancroft

News and Trends 7 Feb 2016

What happened this week? CRISPR, Microbiome, Algae in Biotech

Monday: Huge Milestone: UK Approves CRISPR Editing on Human Embryos Tuesday: Ultimate Review: The Unlimited Biotech Potential of Algae Wednesday: Meet the CEO of Europe’s Leading Microbiome Biotech Thursday: Zika Virus: Who in Biotech is Working to Stop its Spread? Friday: German RNA Specialist Could Break French Biotech into the Cancer Ecosystem Bonus: How we […]

February 7, 2016 - 1 minutemin - By Philip Hemme

Knowledge hub

Categories

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Approaches

Therapeutic areas

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Celebrating the 10th Birthday of this German Infectious Disease Biotech with the CEO

What happened this week? 8 great innovators, PD-L1 combo, Genzyme

World’s Largest Genome Sequencing Project partners with Global Leader in NGS

Biotech of the week: Nordic Nanovector & its ARC technology

Sanofi-Genzyme: Still successful 5 years after the acquisition?

“Actelion could be the First European-born Biopharma to make it to the Major League”

When the Biggest Tech Investors Go Wild for Biotech

Synthetic Biology Breakthrough in Production of Natural Carotenoids

The European Union Finances the Future of CAR-T Manufacturing

French Biotech Launches Phase III Global Trial for Lung Cancer Drug

Here are 8 of Forbes’ Under 30 Year Olds Transforming European Biotech

What happened this week? CRISPR, Microbiome, Algae in Biotech

Subscribe to our newsletter to get the latest biotech news!

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!